166 related articles for article (PubMed ID: 31943428)
1. Candida biofilm production is associated with higher mortality in patients with candidaemia.
Vitális E; Nagy F; Tóth Z; Forgács L; Bozó A; Kardos G; Majoros L; Kovács R
Mycoses; 2020 Apr; 63(4):352-360. PubMed ID: 31943428
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: A single-centre retrospective 4-year analysis from Hungary.
Kovács F; Balla N; Bozó A; Harmath A; Jakab Á; Tóth Z; Nagy F; Majoros L; Kovács R
Mycoses; 2024 Apr; 67(4):e13727. PubMed ID: 38650397
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
[TBL] [Abstract][Full Text] [Related]
4. Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: An observational nine-year single center study in Mexico.
Treviño-Rangel RJ; Peña-López CD; Hernández-Rodríguez PA; Beltrán-Santiago D; González GM
Rev Iberoam Micol; 2018; 35(1):11-16. PubMed ID: 29287632
[TBL] [Abstract][Full Text] [Related]
5. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013.
Rajendran R; Sherry L; Nile CJ; Sherriff A; Johnson EM; Hanson MF; Williams C; Munro CA; Jones BJ; Ramage G
Clin Microbiol Infect; 2016 Jan; 22(1):87-93. PubMed ID: 26432192
[TBL] [Abstract][Full Text] [Related]
6. Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical
Chen YC; Chen FJ; Lee CH
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33252326
[No Abstract] [Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis.
Atiencia-Carrera MB; Cabezas-Mera FS; Tejera E; Machado A
PLoS One; 2022; 17(2):e0263522. PubMed ID: 35113972
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection.
Pannanusorn S; Fernandez V; Römling U
Mycoses; 2013 May; 56(3):264-72. PubMed ID: 23113805
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
Aslan H; Gülmez D
Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
[TBL] [Abstract][Full Text] [Related]
12. In vitro biofilm production of Candida bloodstream isolates: any association with clinical characteristics?
Pongrácz J; Benedek K; Juhász E; Iván M; Kristóf K
J Med Microbiol; 2016 Apr; 65(4):272-277. PubMed ID: 26678484
[TBL] [Abstract][Full Text] [Related]
13. Micafungin is more active against Candida albicans biofilms with high metabolic activity.
Marcos-Zambrano LJ; Escribano P; González del Vecchio M; Bouza E; Guinea J
J Antimicrob Chemother; 2014 Nov; 69(11):2984-7. PubMed ID: 24942468
[TBL] [Abstract][Full Text] [Related]
14. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
[TBL] [Abstract][Full Text] [Related]
15. Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
Int J Med Microbiol; 2014 Nov; 304(8):1192-8. PubMed ID: 25224357
[TBL] [Abstract][Full Text] [Related]
16. Role of Non Albicans Candida Spp. and Biofilm in Neonatal ICU.
Goel S; Mittal S; Chaudhary U
Infect Disord Drug Targets; 2016; 16(3):192-198. PubMed ID: 27538491
[TBL] [Abstract][Full Text] [Related]
17. Candidemia Candida albicans clusters have higher tendency to form biofilms than singleton genotypes†.
Díaz-García J; Arendrup MC; Cantón R; García-Rodríguez J; Gómez A; Gómez E; Orden B; Parisi G; Pemán J; Posteraro B; Sanguinetti M; Da Matta DA; Colombo AL; Muñoz P; Sánchez-Carrillo C; Guinea J; Escribano P
Med Mycol; 2020 Oct; 58(7):887-895. PubMed ID: 32022851
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
Med Mycol; 2016 Feb; 54(2):155-61. PubMed ID: 26543157
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
